Objective: This study aimed to evaluate the use of the subcutaneous implant in the postpartum period at the communal medical center of Coronthie in Conakry. Methods: This was a longitudinal study carried out from1st of July202December 2 to 31, 2022, be oneperiod6 months. Were included, women having gave birth in the service, chosen and received the postpartum contraceptive implant and agreed to participate in the study. The non-inclusion criteria were women with serious maternal complications, post-abortion women and refusal to participate in the study. We carried out an exhaustive recruitment of patients. We performed a simple descriptive analysis with calculation of numbers and percentages. Results: Of a total of 631 patients advise on the different methods of contraception, 117 (18.5%) used the postpartum contraceptive implant. The users of the implant had an average age of 25 years with extremes of 14 years and 45 years and were mainly married (59%), secondary level (41%) exercising a liberal profession (53%) and primiparous (45.3%). They were mainly recommended in the postpartum (47.9%) and the implant was inserted in the immediate postpartum in 73.5% of cases. The majority of users of the implant had presented neither adverse effects (64.1%) nor immediate complications (93.2%). The continuation and satisfaction rates were 87.2% and 79.3% respectively. Conclusion: our study has shown that the use of the postpartum implant is well accepted by patients, resulting in an el rate eve of continuation and satisfaction. Therefore, the implant provides a safe, long-acting contraceptive that can be used by most postpartum patients for birth spacing.
| Published in | Journal of Gynecology and Obstetrics (Volume 11, Issue 4) |
| DOI | 10.11648/j.jgo.20231104.15 |
| Page(s) | 106-110 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2023. Published by Science Publishing Group |
Subcutaneous Implant, Postpartum, Coronthie, Guinea
| [1] | World Health Organization. Providing contraceptive services in the context of HIV treatment programmes. Implementation Tool, 2019. Available at: https://apps.who.int/iris/bitstream/handle/10665/325859/WHO-CDS-HIV-19.19-eng.pdf?ua=1 |
| [2] | Pfitzer A, Mackenzie D, Blanchard H, Hyjazi Y, Kumar S, Lisanework KS, et al. A facility birth can be the time to start family planning: postpartum intrauterine device experiences from six countries. Int J Gynaecol Obstet. 2015; 130 (Suppl 2): S54-61. doi: 10.1016/j. ijgo.2015.03.008. |
| [3] | Multiple Indicator Demographic and Health Survey (EDS-MICS 2018). National Institute of Statistics. Ministry of Planning, Conakry, Guinea. |
| [4] | Pasha O, Goudar SS, Patel A, Garces A, Esamai F, Chomba E, et al. Postpartum contraceptive use and unmet need for family planning in five low-income countries. Reprod Health. 2015; 12 (Supp 2): S11. |
| [5] | WHO: Medical eligibility criteria for contraceptive use. 5th. 2015. (accessed August 17, 2022). |
| [6] | Muthal-Rathore A: Immediate postpartum insertion for intrauterine devices: RHL commentary. The WHO Reproductive Health Library. Geneva: World Health Organization. 2010. (Accessed September 16, 2022). |
| [7] | Pleah T, Hyjazi Y, Austin S, Diallo A, Bao B, Waxman R, et al. Increasing use of postpartum family planning and the postpartum IUD: early experiences in West and Central Africa. Glob Health Sci Pract. 2016; 4 Suppl 2: S140-152. doi: 10.9745/GHSP-D-16-00039. |
| [8] | Tomar B, Saini V, Gupta M. Postpartum intrauterine contraceptive device: acceptability and safety. Int J Reprod Contracept Obstet Gynecol. 2018 May; 7 (5): 2011-2017. |
| [9] | Eluwa GIE, Atamewalen R, Odogwu K, Ahonsi B. Success providing postpartum intrauterine devices in private-sector health care facilities in Nigeria: Factors associated with uptake. Glob Health Sci Pract. 2016; 4 (2): 276-283. doi: 10.9745/GHSP-D-16-00072. |
| [10] | Rossier C, Hellen J. Traditional birthspacing practices and uptake of family planning during the postpartum period in Ouagadougou: qualitative results. Int Perspect Sex Reprod Health. 2014; 40 (2): 87-94. https://doi.org/10.1363/4008714. |
| [11] | Borda MR, Winfrey W, McKaig C. Return to sexual activity and modern family planning use in the extended postpartum period: an analysis of findings from seventeen countries. Afr J Reprod Health. 2010; 14 (4). |
| [12] | Robinson N, Moshabela M, Owusu-Ansah L, Kapungu C, Geller S. Barriers to intrauterine device uptake in a rural setting in Ghana. Health Care Women Int. 2016; 37 (2): 197–215. CrossRef. Medline. |
| [13] | Gueye M, Gaye YFO, Diouf AA, Mbaye M, Niang MM, Gueye SMK, Moreau JC, Diouf A. Intrauterine device inserted during cesarean section. Pilot study carried out at the Center Hospitalier Universitaire de Dakar. Journal of Obstetrics Gynecology and Reproductive Biology (2013), 42: 585-90. |
| [14] | Ingabire R, Nyombayire J, Hoagland A, Da Costa V, Mazzei A, Haddad L, Parker R, Sinabamenye R, Mukamuyango J, Smith J, Umutoni V, Mork E, Allen S, Karita E, Wall KM. Evaluation of a multi-level intervention to improve postpartum intrauterine device services in RwandaGates Open Research 2019, https://doi.org/10.12688/gatesopenres.12854.3 |
| [15] | Jairaj S, Dayyala S. A Cross Sectional Study on Acceptability and Safety of IUCD among Postpartum Mothers at Tertiary Care Hospital, Telangana. Journal of Clinical and Diagnostic Research. 2016 Jan, Vol-10 (1): LC01-LC04. |
| [16] | Bryant AG, Hamela G, Gottert A, Stuart GS, Kamanga G. Reasons for intrauterine device use, discontinuation, and non-use in Malawi: a qualitative study of women and their partners. Afr J Reprod Health. 2015; 19 (4): 50-57. |
| [17] | Haddad LB, Feldacker C, Jamieson DJ, Tweya H, Cwiak C, Bryant AG, et al. Medical eligibility, contraceptive choice, and intrauterine device acceptance among HIV-infected women receiving antiretroviral therapy in Lilongwe, Malawi. Int J Gynaecol Obstet. 2014; 126 (3): 213-216. doi: 10.1016/j.ijgo.2014.03.026, |
| [18] | Tilahun Y, Mehta S, Zerihun H, Lew C., Brooks MI, Nigatu T, et al. Expanding access to the intrauterine device in public health facilities in Ethiopia: A mixed-methods study. Glob Health Sci Pract. 2016; 4 (1): 16-28. doi: 10.9745/GHSP-D-15-00365. |
| [19] | WHO: Medical eligibility criteria for contraceptive use. 5th. 2015; [accessed September 24, 2022]. |
| [20] | Morrison C, Waszak C, Katz K, Diabate F, Mate EM. Clinical outcomes of two early postpartum IUD insertion programs in Africa. Contraception 1996; 53: 17-21. |
| [21] | Glazer Ab, Wolf A, Gorby N. Postpartum contraception: need vs. Reality. Contraception 2011; 83: 238-41. |
| [22] | Lopez LM, Bernholc A, Hubacher D, Stuart G, Van Vliet HA. Immediate postpartum insertion of intrauterine device for contraception. Cochrane Database System Rev. 2015; (6): CD003036. doi: 10.1002/14651858.CD003036.pub3. |
| [23] | Bryant AG, Kamanga G, Stuart GS, Haddad LB, Meguid T, Mhango C. Immediate postpartum versus 6-week intrauterine device insertion: a feasibility study of a randomized controlled trial. Afr J Reprod Health. 2013; 17 (2): 72-79. |
| [24] | Barala S, Maheshwari S, Sharma P. Analysis of awareness, acceptance, safety and continuation rate of placental and intra cesarean insertion of intrauterine contraceptive device. Int J Reprod Contracept Obstet Gynecol. 2017; 5 (6): 1974-80. |
| [25] | Population Services International (PSI), USAID. Helping to Space and Limit Pregnancies to Save Lives: Programmatic Approaches to Improving Access to the Postpartum IUD. Data sheet February (consulted on July 24, 2022). |
APA Style
Leno Daniel William Athanas, Baldé Ousmane, Soumah Aboubacar Fode Momo, Sylla Ibrahima, Conté Ibrahima, et al. (2023). Postpartum Subcutaneous Implant: Use and Follow-Up of Users at the Coronthie Communal Medical Center in Conakry, Guinea in 2022. Journal of Gynecology and Obstetrics, 11(4), 106-110. https://doi.org/10.11648/j.jgo.20231104.15
ACS Style
Leno Daniel William Athanas; Baldé Ousmane; Soumah Aboubacar Fode Momo; Sylla Ibrahima; Conté Ibrahima, et al. Postpartum Subcutaneous Implant: Use and Follow-Up of Users at the Coronthie Communal Medical Center in Conakry, Guinea in 2022. J. Gynecol. Obstet. 2023, 11(4), 106-110. doi: 10.11648/j.jgo.20231104.15
AMA Style
Leno Daniel William Athanas, Baldé Ousmane, Soumah Aboubacar Fode Momo, Sylla Ibrahima, Conté Ibrahima, et al. Postpartum Subcutaneous Implant: Use and Follow-Up of Users at the Coronthie Communal Medical Center in Conakry, Guinea in 2022. J Gynecol Obstet. 2023;11(4):106-110. doi: 10.11648/j.jgo.20231104.15
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.jgo.20231104.15,
author = {Leno Daniel William Athanas and Baldé Ousmane and Soumah Aboubacar Fode Momo and Sylla Ibrahima and Conté Ibrahima and Bah Elhadj Mamoudou and Diallo Mamadou Hady and Moussa Kantara Camara and Sy Telly},
title = {Postpartum Subcutaneous Implant: Use and Follow-Up of Users at the Coronthie Communal Medical Center in Conakry, Guinea in 2022},
journal = {Journal of Gynecology and Obstetrics},
volume = {11},
number = {4},
pages = {106-110},
doi = {10.11648/j.jgo.20231104.15},
url = {https://doi.org/10.11648/j.jgo.20231104.15},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jgo.20231104.15},
abstract = {Objective: This study aimed to evaluate the use of the subcutaneous implant in the postpartum period at the communal medical center of Coronthie in Conakry. Methods: This was a longitudinal study carried out from1st of July202December 2 to 31, 2022, be oneperiod6 months. Were included, women having gave birth in the service, chosen and received the postpartum contraceptive implant and agreed to participate in the study. The non-inclusion criteria were women with serious maternal complications, post-abortion women and refusal to participate in the study. We carried out an exhaustive recruitment of patients. We performed a simple descriptive analysis with calculation of numbers and percentages. Results: Of a total of 631 patients advise on the different methods of contraception, 117 (18.5%) used the postpartum contraceptive implant. The users of the implant had an average age of 25 years with extremes of 14 years and 45 years and were mainly married (59%), secondary level (41%) exercising a liberal profession (53%) and primiparous (45.3%). They were mainly recommended in the postpartum (47.9%) and the implant was inserted in the immediate postpartum in 73.5% of cases. The majority of users of the implant had presented neither adverse effects (64.1%) nor immediate complications (93.2%). The continuation and satisfaction rates were 87.2% and 79.3% respectively. Conclusion: our study has shown that the use of the postpartum implant is well accepted by patients, resulting in an el rate eve of continuation and satisfaction. Therefore, the implant provides a safe, long-acting contraceptive that can be used by most postpartum patients for birth spacing.},
year = {2023}
}
TY - JOUR T1 - Postpartum Subcutaneous Implant: Use and Follow-Up of Users at the Coronthie Communal Medical Center in Conakry, Guinea in 2022 AU - Leno Daniel William Athanas AU - Baldé Ousmane AU - Soumah Aboubacar Fode Momo AU - Sylla Ibrahima AU - Conté Ibrahima AU - Bah Elhadj Mamoudou AU - Diallo Mamadou Hady AU - Moussa Kantara Camara AU - Sy Telly Y1 - 2023/08/22 PY - 2023 N1 - https://doi.org/10.11648/j.jgo.20231104.15 DO - 10.11648/j.jgo.20231104.15 T2 - Journal of Gynecology and Obstetrics JF - Journal of Gynecology and Obstetrics JO - Journal of Gynecology and Obstetrics SP - 106 EP - 110 PB - Science Publishing Group SN - 2376-7820 UR - https://doi.org/10.11648/j.jgo.20231104.15 AB - Objective: This study aimed to evaluate the use of the subcutaneous implant in the postpartum period at the communal medical center of Coronthie in Conakry. Methods: This was a longitudinal study carried out from1st of July202December 2 to 31, 2022, be oneperiod6 months. Were included, women having gave birth in the service, chosen and received the postpartum contraceptive implant and agreed to participate in the study. The non-inclusion criteria were women with serious maternal complications, post-abortion women and refusal to participate in the study. We carried out an exhaustive recruitment of patients. We performed a simple descriptive analysis with calculation of numbers and percentages. Results: Of a total of 631 patients advise on the different methods of contraception, 117 (18.5%) used the postpartum contraceptive implant. The users of the implant had an average age of 25 years with extremes of 14 years and 45 years and were mainly married (59%), secondary level (41%) exercising a liberal profession (53%) and primiparous (45.3%). They were mainly recommended in the postpartum (47.9%) and the implant was inserted in the immediate postpartum in 73.5% of cases. The majority of users of the implant had presented neither adverse effects (64.1%) nor immediate complications (93.2%). The continuation and satisfaction rates were 87.2% and 79.3% respectively. Conclusion: our study has shown that the use of the postpartum implant is well accepted by patients, resulting in an el rate eve of continuation and satisfaction. Therefore, the implant provides a safe, long-acting contraceptive that can be used by most postpartum patients for birth spacing. VL - 11 IS - 4 ER -
Information
Email: